4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerBreast Cancer RecurrentActive, not recruitingPhase 32026-09-03NCT03820830
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsSolid Tumor, AdultRecruitingPhase 1 / Phase 22026-06-25NCT04219254
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid TumoursSolid TumoursRecruitingPhase 1 / Phase 22026-05-08NCT06725758
Treatment for Ph-negative ALL for Adults up to 65 YearsHemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmNot yet recruitingNot applicable2026-03-02NCT07443592